ChIP-seq studies using human ETP-ALL explants identified several binding sites for LMO2 within the regulatory regions of the FLT3 locus associated with open chromatin that is normally closed in DN3 thymocytes (Fig. 5B). The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.